» Articles » PMID: 24194897

Down-regulation of MiR-129-5p Inhibits Growth and Induces Apoptosis in Laryngeal Squamous Cell Carcinoma by Targeting APC

Overview
Journal PLoS One
Date 2013 Nov 7
PMID 24194897
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

miRNAs regulate gene expression and are key mediators of tumourigenesis. miR-129 has diverse effects in tumours, but its role in laryngeal squamous cell carcinoma (LSCC) remains unknown. This article focuses on the role of miR-129-5p in LSCC. We show miR-129-5p is upregulated in primary LSCC tumours and correlated with advanced disease. Down-regulating miR-129-5p suppressed cell proliferation and migration, and caused cell cycle arrest in Hep-2 cell lines. Downregulation of miR-129-5p alone is sufficient to induce apoptosis both in vivo and in vitro. Moreover, the growth of LSCC xenograft exposed to miR-129-5p antisense oligonucleotides (ASO) in BALB/c mice was markedly inhibited. In addition, we found that miR-129-5p targeted adenomatous polyposis coli (APC) to release inhibition of Wnt signalling causing cell growth and tumourigenesis. Our results suggest miR-129-5p functions as an oncogene in LSCC by repressing APC and is a potential therapeutic target for LSCC.

Citing Articles

Ethanol induces replication fork stalling and membrane stress in immortalized laryngeal cells.

Hoes L, Voordeckers K, Dok R, Boeckx B, Steemans B, Gopaul D iScience. 2024; 26(12):108564.

PMID: 38213791 PMC: 10783606. DOI: 10.1016/j.isci.2023.108564.


Diagnostic and Prognostic Value of microRNAs in Patients with Laryngeal Cancer: A Systematic Review.

Broseghini E, Filippini D, Fabbri L, Leonardi R, Abeshi A, Molin D Noncoding RNA. 2023; 9(1).

PMID: 36827542 PMC: 9966707. DOI: 10.3390/ncrna9010009.


Overview on Molecular Biomarkers for Laryngeal Cancer: Looking for New Answers to an Old Problem.

Falco M, Tammaro C, Takeuchi T, Cossu A, Scafuro G, Zappavigna S Cancers (Basel). 2022; 14(7).

PMID: 35406495 PMC: 8997012. DOI: 10.3390/cancers14071716.


Spectrum of microRNAs and their target genes in cancer: intervention in diagnosis and therapy.

Dayakar A, Shanmukha K, Kalangi S Mol Biol Rep. 2022; 49(7):6827-6846.

PMID: 35031927 DOI: 10.1007/s11033-021-07040-2.


Identification of colorectal cancer associated biomarkers: an integrated analysis of miRNA expression.

Fonseca A, Ramalhete S, Mestre A, Pires das Neves R, Marreiros A, Castelo-Branco P Aging (Albany NY). 2021; 13(18):21991-22029.

PMID: 34547721 PMC: 8507258. DOI: 10.18632/aging.203556.


References
1.
Dreher A, Rossing M, Kaczkowski B, Andersen D, Larsen T, Christophersen M . Differential expression of cellular microRNAs in HPV 11, -16, and -45 transfected cells. Biochem Biophys Res Commun. 2011; 412(1):20-5. DOI: 10.1016/j.bbrc.2011.07.011. View

2.
Ogawa R, Ishiguro H, Kuwabara Y, Kimura M, Mitsui A, Katada T . Expression profiling of micro-RNAs in human esophageal squamous cell carcinoma using RT-PCR. Med Mol Morphol. 2009; 42(2):102-9. DOI: 10.1007/s00795-009-0443-1. View

3.
Verras M, Sun Z . Roles and regulation of Wnt signaling and beta-catenin in prostate cancer. Cancer Lett. 2005; 237(1):22-32. DOI: 10.1016/j.canlet.2005.06.004. View

4.
Mirisola V, Mora R, Esposito A, Guastini L, Tabacchiera F, Paleari L . A prognostic multigene classifier for squamous cell carcinomas of the larynx. Cancer Lett. 2011; 307(1):37-46. DOI: 10.1016/j.canlet.2011.03.013. View

5.
Mulholland D, Dedhar S, Coetzee G, Nelson C . Interaction of nuclear receptors with the Wnt/beta-catenin/Tcf signaling axis: Wnt you like to know?. Endocr Rev. 2005; 26(7):898-915. DOI: 10.1210/er.2003-0034. View